title: Is TGFBR1*6A really associated with increased risk of cancer?
authors.forename: Hong-Tao
authors.initials: HT
authors.lastname: Zhang
authors.forename: Jun
authors.initials: J
authors.lastname: Zhao
authors.forename: Shi-Ying
authors.initials: SY
authors.lastname: Zheng
authors.forename: Xiao-Feng
authors.initials: XF
authors.lastname: Chen
mesh_terms: D030201:Activin Receptors, Type I / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D015201:Meta-Analysis as Topic; D009154:Mutation / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases; D000077293:Receptor, Transforming Growth Factor-beta Type I; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics*; D012307:Risk Factors
chemical_list: D018125:Receptors, Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D030201:Activin Receptors, Type I; D000077293:Receptor, Transforming Growth Factor-beta Type I; C000625841:TGFBR1 protein, human